Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. 2002

E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
Neurology CEDD, GlaxoSmithKline Pharmaceuticals, New Frontiers Science Park (N) H25/119, Harlow, Essex, CM19 5AW, UK. elaine_a_irving@gsk.com

The orexins (hypocretins) have recently been implicated in neurodegeneration associated with narcolepsy. Therefore, the current study was designed to investigate changes in the expression of prepro-orexin and the orexin receptors, OX1R and OX2R following permanent middle cerebral artery occlusion (MCAO) in the rat. Six and twenty-four hours following MCAO, increased OX1R mRNA and protein expression (as assessed by Western blotting and immunohistochemistry) was detected in the ischaemic cortex compared with control tissue. In contrast, however, no increase in OX2R mRNA was detected at any time-point and prepro-orexin levels in the cortex were below assay detection levels. This study shows that orexin receptor localization is altered following cerebral ischaemia. The development of selective orexin receptor antagonists will be crucial in establishing a role for this family of novel peptides in the mechanisms underlying ischaemic cell death.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D009410 Nerve Degeneration Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways. Neuron Degeneration,Degeneration, Nerve,Degeneration, Neuron,Degenerations, Nerve,Degenerations, Neuron,Nerve Degenerations,Neuron Degenerations
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D011498 Protein Precursors Precursors, Protein
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000068797 Orexins Neuropeptide hormones that play a role in regulating a variety of behavioral and physiological processes in response to motivational stimuli. Hypocretin,Orexin,Hypocretin-1,Hypocretin-2,Hypocretins,Orexin-A,Orexin-B,Hypocretin 1,Hypocretin 2,Orexin A,Orexin B

Related Publications

E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
July 2006, Neuroreport,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
January 1995, Fundamental & clinical pharmacology,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
July 1999, Brain research,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
January 2002, Neuroscience,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
January 1983, Acta neuropathologica,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
February 2019, Neuroreport,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
June 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
June 2004, Journal of neurochemistry,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
June 1995, Stroke,
E A Irving, and D C Harrison, and A J Babbs, and A C Mayes, and C A Campbell, and A J Hunter, and N Upton, and A A Parsons
January 2005, Neuroscience letters,
Copied contents to your clipboard!